1 of 1
Story summary
- A study of over 100,000 mammograms shows the AI tool Mirai significantly improves detection of interval breast cancers.
- Conducted by researchers at the University of Cambridge and published in Radiology, the study found Mirai identified 42.4% of interval cancers in the highest risk group.
- The AI tool outperformed traditional methods, particularly within the first year post-screening.
- Future studies will focus on economic modeling and clinical trials to validate these findings.
